505(b)(2) Standards Needed To Ensure Predictability – Pfizer Attorney
Executive Summary
FDA should develop standards for use of the 505(b)(2) approval pathway to better allow for predictability of its application, according to Pfizer Assistant General Council Jeffrey Chasnow